Moderna shares surge after U.S. FDA to consider its flu shot
Pharmaceutical company Moderna surged 8 percent in U.S. premarket trading after the announcement that the U.S. FDA will consider its flu shot.
BusinessPharmaceutical company Moderna surged 8 percent in U.S. premarket trading after the announcement that the U.S. FDA will consider its flu shot.
BusinessThe battered shares of Danish pharmaceutical giant Novo Nordisk are rising sharply, up 7 percent on the Copenhagen Stock Exchange.
BusinessYou're up to date in : s läkemedelsmyndighet FDA
That's every story in : s läkemedelsmyndighet FDA for now.